Oncocross Co., Ltd. (KOSDAQ: A382150)
Health Care · Biotechnology · KR
₩3,200.00
-12.45% today · -62.8% 1Y
Oncocross Co., Ltd. (KOSDAQ: A382150) operates in the Biotechnology industry within the Health Care sector. The company is valued at $31.31M.
Over the last twelve months the share price has lost 62.8%, trading between 2.23K and 14.49K.
Tweenvest scores Oncocross Co., Ltd. across four factors: quality 38/100, value 22/100, growth 74/100. Its strongest factor is growth.
A382150 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $31.31M
- Revenue (TTM)
- $255.39K
- P/E
- —
- EPS
- -805.02
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩14,490.00
- 52-week low
- ₩2,235.00
- Avg volume (3M)
- —
- Shares outstanding
- 13.05M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S.IBSE: ANGEN | $31.63M | TL7.12 | -13.59% |
| GeneOne Life Science, Inc.KOSE: A011000 | $31.40M | ₩— | — |
| Medicure Inc.TSXV: MPH | $31.36M | CA$4.25 | +42.62% |
| Organoidsciences Ltd.KOSDAQ: A476040 | $31.32M | ₩6,340.00 | -7.45% |
| Metagenomi Therapeutics, Inc.NasdaqGS: MGX | $30.83M | $0.82 | -1.52% |
| Sernova Biotherapeutics IncTSX: SVA | $30.70M | CA$0.12 | 0.00% |
| Raphael Pharmaceutical Inc.OTCPK: RAPH | $30.47M | $1.51 | — |
| HLB Pep Co., Ltd.KOSDAQ: A196300 | $30.38M | ₩4,320.00 | -17.24% |
Figures last refreshed Oct 18, 2026.